Dexcom Announces Upcoming Conference Presentations

SAN DIEGO--(BUSINESS WIRE)--Sep. 1, 2022-- DexCom, Inc. (NASDAQ:DXCM) today announced that Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present an update on the company at the following upcoming investor conferences:

  • Wells Fargo 2022 Healthcare Conference on Wednesday, September 7, 2022 at 2:35pm (EST).
  • Baird 2022 Global Healthcare Conference on Wednesday, September 14, 2022 at 8:30am (EST).

Links to the webcasts will be available on the Dexcom Investor Relations website at investors.dexcom.com and will be archived there for future reference.

About DexCom, Inc.

DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) products. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of patients, caregivers, and clinicians, Dexcom simplifies and improves diabetes management around the world.

DexCom, Inc.
Sean Christensen
Senior Director – Investor Relations and Corporate FP&A
investor-relations@dexcom.com
(858) 200-0200

Source: DexCom, Inc.